Clinical Trials Directory

Trials / Conditions / VHL Syndrome

VHL Syndrome

5 registered clinical trials studyying VHL Syndrome — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingOvertaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
NCT06195150
IRCCS San Raffaele—
RecruitingEstablishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell
NCT06391879
Peking University First Hospital—
UnknownFrequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
NCT05534854
RenJi Hospital—
Active Not RecruitingA Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associate
NCT03401788
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 2
CompletedMK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK
NCT03108066
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 2